Poster #220 INTRANASAL OXYTOCIN EFFECTS ON SOCIAL ANXIETY AND DEPRESSION IN SCHIZOPHRENIA: RESULTS FROM A DOUBLE BLIND PLACEBO CONTROLLED TRIAL
Heidi J. Wehring(University of Maryland, Baltimore), Deanna L. Kelly(University of Maryland, Baltimore), Mary R. Lee(National Institute on Drug Abuse), Jared Linthicum(University of Maryland, Baltimore), Robert P. McMahon(Valneva (Austria)), Carlo Contoreggi, Ann Marie Kearns(University of Maryland, Baltimore), Stephanie Feldman(University of Maryland, Baltimore), Charles Richardson(Los Alamos National Laboratory), Alan S. Bellack(Drexel University), Robert W. Buchanan(University of Maryland, Baltimore), Gopal Vyas(University of Maryland, Baltimore)
Cited by 2
Related Papers
Treatment-Resistant Schizophrenia: Treatment Response and Resistance in Psychosis (TRRIP) Working Group Consensus Guidelines on Diagnosis and Terminology
|American Journal of Psychiatry|2016|1.1k
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|915
The 2009 Schizophrenia PORT Psychosocial Treatment Recommendations and Summary Statements
|Schizophrenia Bulletin|2009|781
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2003
|Schizophrenia Bulletin|2004|768
The Schizophrenia Patient Outcomes Research Team (PORT): Updated Treatment Recommendations 2009
|Schizophrenia Bulletin|2009|501